published by xavier.grehant on 2026-05-15

Contemplative Practice and Parkinson's Disease

A Scientific and Cross-Cultural Inquiry into Meditation, Non-Dual Traditions, and Neurodegenerative Illness

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorder and the fastest-growing neurological condition worldwide. Its central pathology — progressive loss of dopaminergic neurons in the substantia nigra, alpha-synuclein aggregation, and chronic neuroinflammation — is increasingly understood as a multi-system disease involving the autonomic nervous system, gut, and stress-response circuitry, not merely a motor disorder of the basal ganglia. In parallel, neuroimaging and clinical research over the past two decades has demonstrated that contemplative practices drawn from yogic and Buddhist traditions act on precisely these systems: striatal dopamine release, vagal tone, HPA-axis regulation, neuroinflammation, BDNF expression, and cortico-striatal connectivity. This paper synthesizes the empirical evidence, traces the relevant neurobiological mechanisms, and situates the findings within the intellectual frameworks of Advaita Vedānta, jñāna yoga, bhakti yoga, and karma yoga — the path of non-attached action, whose mapping onto the action–reward circuitry that fails in PD is unusually direct. The aim is neither romantic affirmation nor reductive dismissal but a sober reading of where ancient contemplative technologies and modern neuroscience genuinely converge — and where they do not.

1. Introduction: The Question Reframed

The intuition that meditation should affect a neurodegenerative disease like Parkinson's rests on a simple premise: if mental states are brain states, then sustained changes in mental activity must produce sustained changes in brain biology. The premise is now uncontroversial in neuroscience. What is less obvious is whether the specific kinds of mental cultivation developed in the Indic contemplative traditions — Advaita's self-inquiry, jñāna yoga's discriminative knowledge, bhakti yoga's devotional absorption, karma yoga's discipline of non-attached action, Patanjali's eight-limbed path — engage neural systems that are specifically relevant to the pathophysiology of Parkinson's.

The honest answer is: in many cases, yes. The dopaminergic system, the vagus nerve, the inflammatory cascade, and the cortico-striatal circuits that fail in PD are also the systems most clearly modulated by contemplative practice. This is not a coincidence of metaphor. It is a convergence at the level of measurable biology.

What follows is an attempt to articulate that convergence with intellectual honesty in both directions — taking the science seriously and taking the traditions seriously as serious knowledge systems, while refusing the temptation to oversell either.

2. The Disease We Are Talking About

Parkinson's disease is defined clinically by bradykinesia, rigidity, resting tremor, and postural instability. The underlying pathology, however, is broader and now thought to begin years or decades before motor symptoms appear.

Core pathology

Progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta, with downstream depletion of dopamine in the striatum (putamen and caudate).
Accumulation of misfolded alpha-synuclein (α-syn) into Lewy bodies, with prion-like trans-synaptic propagation between connected brain regions.
Chronic neuroinflammation, mediated by activated microglia and astrocytes, producing pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and reactive oxygen species.
Mitochondrial dysfunction and oxidative stress in vulnerable neurons.

The Braak hypothesis and the gut–brain axis

A substantial body of evidence now supports the view that PD pathology may begin outside the brain. Braak and colleagues proposed in 2003 that α-synuclein aggregates form first in the olfactory bulb and the dorsal motor nucleus of the vagus, then ascend the vagus nerve from the enteric nervous system to the brainstem and finally the midbrain (Liddle 2018; Hawkes et al. 2010). Recent reviews (Kwon et al. 2025; Travagli et al. 2024) document the convergent evidence: gut dysbiosis, intestinal hyperpermeability, lipopolysaccharide-driven inflammation, and α-syn accumulation in the enteric nervous system frequently precede motor symptoms by years. Prodromal constipation, hyposmia, and REM sleep behavior disorder fit this picture.

Non-motor and psychiatric burden

Depression, anxiety, apathy, impulse-control disorders, autonomic dysfunction (constipation, orthostatic hypotension, urinary urgency), sleep disorders, and mild cognitive impairment are not "secondary" complications but intrinsic features of the disease, often present in the prodromal phase and tightly coupled to motor decline. Chronic psychological stress accelerates dopaminergic loss in animal models (Hemmerle, Herman & Seroogy 2012) and worsens clinical course in patients (van der Heide et al. 2021).

This is the territory on which any candidate intervention — pharmacological or contemplative — must act.

3. The Neuroscience of Meditation: What Actually Changes

The neuroscientific literature on meditation is now large enough to support meta-analyses of meta-analyses. The findings most relevant to PD cluster around five mechanisms.

3.1 The dopaminergic system

The most direct evidence comes from a landmark PET study by Kjaer et al. (2002), in which eight experienced practitioners of Yoga Nidra were scanned with ¹¹C-raclopride, a radioligand that competes with endogenous dopamine for D2 receptors. During meditation, raclopride binding in the ventral striatum decreased by approximately 7.9%, corresponding to a 65% increase in endogenous dopamine release. The change correlated significantly with increases in EEG theta activity, the characteristic signature of deep meditative states.

This was the first in vivo demonstration of an endogenous neurotransmitter release coupled to a meditative experience. Subsequent work has extended the finding: focused attention meditation activates and induces plastic changes in mesolimbic dopaminergic targets, particularly the anterior cingulate cortex and striatum (Kirk & Montague 2015). Long-term meditators show altered tonic dopamine levels and altered feedback-based learning consistent with chronic adaptation of the system.

The relevance to PD is direct. The disease is defined by failure of precisely this system. While meditation cannot regenerate lost substantia nigra neurons, it appears to potentiate residual dopaminergic function in the very target region that is depleted.

3.2 Vagal tone and the autonomic nervous system

Slow, controlled breathing — central to virtually every contemplative tradition — increases parasympathetic tone via stimulation of the vagus nerve. Heart rate variability (HRV), a non-invasive marker of vagal tone, increases reliably with meditation and pranayama (Brown & Gerbarg 2005; Toschi-Dias et al. 2017). Sudarshan Kriya Yoga, a sequence of ujjayi, bhastrika, and the rhythmic Sudarshan Kriya itself, has been shown to enhance cardiac-respiratory synchronization and improve autonomic balance in healthy practitioners and in patients with anxiety-depressive disorders.

This is significant for PD for two reasons. First, autonomic dysfunction is intrinsic to the disease. Second, the vagus is the proposed conduit for prion-like α-synuclein propagation from gut to brainstem (Liddle 2018). A 2025 comprehensive review by Wang et al. on vagus nerve stimulation in PD describes two synergistic pathways: peripherally, modulation of gut microbiota composition with reduced LPS and increased short-chain fatty acids, attenuated intestinal inflammation, and inhibition of α-syn propagation; centrally, attenuation of microglial activation, reduction of TNF-α, IL-1β, and reactive oxygen species, increased BDNF, and protection of dopaminergic neurons. While that review concerns implanted electrical stimulation, the mechanistic targets overlap substantially with what slow breathing and pranayama achieve non-invasively.

3.3 Neuroinflammation and oxidative stress

A pilot RCT by Cheung et al. (2018) at the University of Minnesota examined Hatha yoga in PD patients with measurement of oxidative stress markers, finding favorable trends. A 2023 network meta-analysis (Wang et al., Frontiers in Psychology) concluded that mind-body practices including yoga, qigong, and Tai Chi exert their benefit in PD partly through neurotrophic factors (BDNF, IGF-1, VEGF) supporting hippocampal neuroplasticity, and reduction of psycho-neuro-immune markers including cortisol and cytokines. A 2025 review specifically focused on yoga in neurodegenerative disease (Tella et al.) summarizes the molecular evidence: yoga enhances BDNF, reduces pro-inflammatory cytokines IL-6 and TNF-α, mitigates oxidative stress, and may preserve gray matter volume in key brain regions.

3.4 Stress, HPA axis, and cortico-limbic regulation

Chronic stress depletes dopaminergic neurons in animal models, elevates cortisol, and accelerates neurodegeneration. The viewpoint paper by van der Heide et al. (2021) in Movement Disorders synthesizes the case for mindfulness as a targeted intervention against this stress-acceleration pathway in PD. Mindfulness training reduces amygdala reactivity, enhances functional connectivity between the amygdala and the ventromedial prefrontal cortex, and improves top-down emotion regulation (Kral et al. 2018). At the network level, sustained practice modulates the balance between the default mode network, the salience network, and the central executive network — the same triadic system whose dysregulation is implicated in depression, rumination, and the non-motor symptoms of PD.

3.5 Structural neuroplasticity

A randomized controlled longitudinal MRI study by Pickut et al. (2013) demonstrated structural brain changes in PD patients following a mindfulness-based intervention, with increased gray matter density in regions including the caudate and the amygdala. A larger meta-analysis by Fox et al. (2014) of 21 studies and roughly 300 meditation practitioners identified consistent morphometric differences in eight brain regions, including the anterior cingulate, insula, somatomotor regions, and orbitofrontal cortex — regions implicated in the functional networks mediating both meditation benefits and the cognitive-emotional sequelae of PD.

4. Clinical Evidence in Parkinson's Disease Specifically

Beyond mechanism, the relevant question is whether contemplative interventions produce clinically meaningful outcomes in PD patients. The evidence is now substantial enough for systematic review.

4.1 Meta-analytic findings

Liu and Lu (2023), in a systematic review and meta-analysis of nine randomized controlled trials covering 337 PD patients, found that mindfulness and meditation therapies produced statistically significant improvement in the motor subscale of the Unified Parkinson's Disease Rating Scale (UPDRS-III) compared with control conditions. Improvements in cognitive measures were modest but consistent. Effects on depression, anxiety, gait velocity, quality of life, and sleep did not reach significance in pooled analysis, partly reflecting heterogeneity of interventions and small sample sizes in individual trials.

A 2023 network meta-analysis (Wang et al.) compared multiple non-pharmacological motor- and sensory-based interventions in PD and identified yoga, qigong, Tai Chi, and dance as the most consistently effective, with the first three sharing the common feature of being mindfulness-guided physical activities emphasizing coordination of breath, attention, and movement.

4.2 Notable individual trials

Hong Kong mindfulness vs. exercise RCT (Kwok et al. 2019, 2022). A modified mindfulness program compared with stretching and resistance training in 68 mild-to-moderate PD patients. Mindfulness produced significantly greater improvement in depressive symptoms at 8 weeks and in emotional non-reactivity at 20 weeks, with comparable benefits on cognition. The authors propose that mindfulness should be integrated into motor-oriented rehabilitation protocols.
Mindfulness pilot with fMRI (Mizuno et al. 2022, PLOS ONE). Twenty PD patients in an 8-week mindfulness program showed reduced impulsivity (Barratt Impulsiveness Scale) with corresponding changes in resting-state functional connectivity — a relevant outcome given the high prevalence of impulse control disorders in PD, often related to dopaminergic medication.
Walking meditation RCT (Mitarnun et al. 2022). Home-based Buddhist walking meditation reduced disease severity and anxiety in PD patients in a randomized controlled design.
Mindfulness yoga RCT (Kwok et al. 2019, JAMA Neurology). A trial of 138 PD patients showed mindfulness yoga produced superior therapeutic effects on motor and psychological outcomes compared with stretching-resistance exercise.
MRI structural changes (Pickut et al. 2013). A randomized controlled longitudinal trial demonstrated structural brain changes on MRI following mindfulness-based intervention in PD.

The pattern is consistent: contemplative interventions reliably improve non-motor symptoms (depression, anxiety, impulsivity, quality of life), produce modest improvement in motor outcomes, and show measurable correlates in brain structure and function. They do not reverse the disease.

5. What the Traditions Actually Teach

To engage Advaita Vedānta, jñāna yoga, bhakti yoga, and karma yoga responsibly is to encounter knowledge systems with their own internal logic, developed over millennia, that should be read on their own terms before being mapped onto neuroscience. The four are not alternative therapies but complementary facets of a single architecture, classically articulated in the Bhagavad Gītā: jñāna provides the metaphysical clarity that one is not, at the deepest level, the doer; bhakti supplies the emotional energy that prevents practice from collapsing into either dry duty or detached inquiry; karma reorganizes action so that it does not bind the agent; and Patañjali's eight-limbed path supplies the graded technical training in attention and autonomic regulation that makes all of this possible. Each axis engages different neurobiology; together they constitute a coherent system, which is why the Gītā presents them not as choices but as facets a serious practitioner integrates.

5.1 Advaita Vedānta and jñāna yoga

Advaita ("not-two") is the non-dualist school of Vedānta systematized by Śaṅkara in the eighth century, drawing on the Upaniṣads, the Brahma Sūtras, and the Bhagavad Gītā. Its central claim is that the apparent multiplicity of phenomena is vivartavāda — an appearance superimposed on a single, undivided reality (Brahman), which is identical with the deepest ground of subjective awareness (Ātman). The practice is jñāna yoga, the yoga of knowledge: discriminative inquiry (viveka), negation of false identifications (neti, neti — "not this, not this"), and direct self-inquiry (ātma-vicāra).

The two most influential twentieth-century exponents — Ramana Maharshi (1879–1950) and Nisargadatta Maharaj (1897–1981) — both taught that the most direct path is the inquiry ko'ham / "Who am I?" or attention to the self-evident sense "I am" prior to any qualification. Ramana emphasized that the body and its afflictions are real at one level of description but not at the deepest. He famously continued to teach during his terminal sarcoma, declining surgery beyond a certain point and describing the dying body in the third person.

This is the first thing to note honestly: the great teachers of the non-dual traditions were not bodily immortal, and they did not claim to be. Nisargadatta died of throat cancer. Ramakrishna died of throat cancer. Ramana died of sarcoma. The realization they pointed to is not protection from biology; it is a fundamental change in what one takes oneself to be, and therefore in one's relation to suffering. To present Advaita as a treatment for Parkinson's would be to misrepresent it.

What Advaita and jñāna yoga do offer, in terms a neuroscientist can engage:

Sustained training in metacognitive awareness — the capacity to observe mental events as events rather than as identifications.
A practice of disengagement from automatic narrative self-construction, which corresponds neurally to reduced default-mode-network dominance.
A framework in which the suffering caused by identification with a failing body is itself addressable, independent of the body's condition.

5.2 Bhakti yoga

Bhakti yoga, the path of devotion, works on a different axis. Its lineages — Vaiṣṇava, Śaiva, the Tamil bhakti saints, the Sant tradition of Kabir and Mirabai, the ecstatic streams of Caitanya and Ramakrishna — emphasize the transformative power of love directed at a personal form of the absolute. The practices include kīrtana (chant), japa (mantra repetition), nāmasmaraṇa (remembrance of the divine name), ritual worship, and surrender (śaraṇāgati).

Neurologically, bhakti practices engage:

The dopaminergic reward system through rhythmic, emotionally charged chant and music (the well-documented "groove" effect of rhythmic entrainment).
The oxytocinergic system through experiences of love, surrender, and attachment to a benevolent figure.
Reduced rumination and self-referential processing through absorption in the object of devotion.
Strong parasympathetic activation through long, sustained vocal practice (kīrtana involves prolonged exhalation, like chanting "Om").

The bhakti claim is not that one transcends the body but that one's deepest emotional energies become reorganized around something other than self-concern. This is therapeutically powerful in chronic illness for reasons obvious to clinical psychology: meaning, community, sustained positive affect, and the dissolution of isolation.

5.3 Karma yoga

Karma yoga is the third great path of the Bhagavad Gītā and, in the Gītā's own architecture, the foundation on which jñāna and bhakti rest. Its central principle, given in 2.47, is niṣkāma karma — action without attachment to its fruits — completed by 2.50, yogaḥ karmasu kauśalam, "yoga is skill in action." Krishna's argument to Arjuna is that action cannot be avoided, so the practical question is not whether to act but how: with full investment in doing the thing well, while releasing the grip on what it produces. Vivekananda's Karma Yoga lectures (1896) and Gandhi's lifelong reading of the Gītā remain its clearest modern expressions; Ramana, asked about renunciation of action, offered the characteristic non-dual gloss that it is not action that binds, but the sense of being its doer.

The mapping onto PD neurobiology is, perhaps unexpectedly, the most direct of any of the paths. The dopaminergic system is at its core a system of action–outcome coupling: phasic dopamine encodes reward prediction errors, the difference between expected and actual results of action. PD disrupts this system, producing not only motor symptoms but characteristic disturbances of motivation, anticipation, and reward — apathy at one extreme, impulse-control disorders (often medication-related) at the other. Karma yoga is, in effect, a multi-millennia-old protocol for uncoupling action from outcome-craving — the very dimension that becomes dysregulated. Its closest modern clinical analogue is Acceptance and Commitment Therapy (ACT), now studied in PD with positive findings on psychological flexibility and mood (Bogosian et al. 2022; Ghielen et al. 2017); its phenomenological analogue is the flow state, characterized by transient hypofrontality and reduced self-referential processing (Csikszentmihalyi 1990; Dietrich 2003). Tai Chi and qigong — among the better-evidenced movement therapies for PD — are karma-yogic in structure: full commitment to the movement, release of the grip on doing-it-correctly.

For a patient facing progressive disease, the practical claim is concrete: the value of an action does not depend on its outcome. This reframes physiotherapy, daily tasks, and the medical encounter as practice grounds rather than means to a cure that may not arrive — addressing precisely the territory where depression and apathy in PD do their worst damage. The karma-yogic ethic of seva (selfless service) extends this further: sustained engagement in meaningful action toward others correlates with reduced systemic inflammation, better mood, and slower cognitive decline in the gerontological literature, supplying a behavioural prescription with measurable biological correlates.

5.4 Patanjali's framework and its mapping

Patañjali's Yoga Sūtras (c. 4th century CE) outline an eight-limbed path (aṣṭāṅga yoga): ethical restraints (yama), observances (niyama), posture (āsana), breath regulation (prāṇāyāma), withdrawal of senses (pratyāhāra), concentration (dhāraṇā), meditation (dhyāna), and absorption (samādhi). The system is not merely physical exercise but a graded training in autonomic regulation, attention, and metacognition.

Each limb maps onto measurable neurobiology. Prāṇāyāma directly modulates vagal tone. Pratyāhāra corresponds to top-down attentional gating. Dhāraṇā and dhyāna train sustained focused attention and open monitoring respectively — the two practice families that have been most extensively studied in cognitive neuroscience.

5.5 The lineages and their living scholarship

It is worth naming the genuine scholars who have built bridges between the traditions and rigorous practice, since the field is also full of less serious figures:

Swami Vivekananda (1863–1902) — his Jnana Yoga, Bhakti Yoga, Karma Yoga, and Raja Yoga lectures remain among the most precise modern expositions.
Swami Sarvapriyananda (Vedanta Society of New York) — contemporary, philosophically rigorous, engages with Western philosophy of mind.
Eknath Easwaran — accessible scholarly translations of the Gītā, Upaniṣads, Dhammapada.
B. K. S. Iyengar and T. K. V. Desikachar — therapeutic application of Patanjali's framework, including documented work with neurological patients.
Sri Sri Ravi Shankar and the Art of Living Foundation — developed Sudarshan Kriya, the breathing-focused practice that has accumulated the largest body of clinical research among Indic-derived techniques.
Jon Kabat-Zinn — adapted Buddhist mindfulness for medical settings (MBSR), enabling most of the clinical research cited above.
Richard Davidson (Center for Healthy Minds, Wisconsin) — contemplative neuroscience.
Stephen Porges — polyvagal theory; collaborated on Sudarshan Kriya research.

6. The Honest Synthesis

Where does the convergence actually lie?

At the level of biology, contemplative practices act on:

The dopaminergic system — the system that fails in PD.
The vagus nerve — the proposed conduit of α-synuclein propagation and a regulator of gut, immune, and brainstem function.
The neuroinflammatory cascade — a major driver of neurodegeneration.
BDNF and other neurotrophic factors — supporting whatever neuroplasticity remains.
The HPA axis and stress-related noradrenergic activation — which accelerate disease progression.
Cortico-striatal and cortico-limbic connectivity — implicated in both motor and non-motor PD symptoms.

These are not vague "wellness" effects. They are mechanistic intersections with the precise pathways of the disease.

At the level of experience, contemplative traditions offer:

Sustained training in attention, which improves cognitive function and may slow cognitive decline.
Emotion regulation that reduces depression, anxiety, and impulsivity — all major non-motor burdens of PD.
A reorganization of the relationship between action and outcome — the karma-yogic dimension — which directly addresses the dysregulation of the action–reward loop characteristic of PD, and sustains engagement with therapy and daily life despite progressive decline.
A framework for living with chronic illness that does not require the illness to disappear in order for suffering to be addressed.
Community, meaning, and ritual structure that sustain practice across years.

What the convergence does not establish:

That meditation cures Parkinson's. It does not.
That contemplative practice can substitute for dopaminergic medication. It cannot.
That progression of α-synucleinopathy can be halted by mental training alone. There is no evidence for this.
That advanced realization confers bodily protection. The historical record of the realizers themselves contradicts this.

The defensible claim is more modest and more interesting: contemplative practices are biologically active interventions that affect the same systems disrupted in PD, that produce clinically measurable improvements in non-motor and probably motor outcomes, and that offer a coherent framework for living with the disease that addresses dimensions of suffering pharmacology cannot reach.

7. Practical Implications

For a person facing PD, or interested in PD prevention, the evidence supports a graduated, integrative approach:

Strongest evidence base:

Mindfulness-based stress reduction (MBSR) and mindfulness-based cognitive therapy (MBCT), 8-week protocols.
Yoga as practiced in clinical trials — Hatha or Iyengar styles, modified for the patient's mobility.
Tai Chi and qigong, particularly for balance, fall prevention, and parasympathetic regulation.

Strong physiological rationale, growing evidence:

Pranayama and Sudarshan Kriya for autonomic regulation.
Walking meditation (the Buddhist kinhin tradition; also embedded in modern protocols).
Yoga Nidra for dopaminergic effects and parasympathetic activation.

Complementary, less directly studied in PD:

Self-inquiry / ātma-vicāra practices from Advaita lineages — for the psychological-existential dimension of chronic illness.
Bhakti practices (kīrtana, mantra) — for affect regulation, community, and meaning.
Karma-yogic reorientation of daily action, with Acceptance and Commitment Therapy as its most directly evidenced clinical analogue — applicable without formal protocol by treating physiotherapy, daily tasks, and the medical encounter themselves as practice grounds.

Critical caveats:

Contemplative practice complements but does not replace levodopa or other PD medications.
Practice should be guided by competent instructors and, where possible, coordinated with the neurology team.
"Vigorous" pranayama practices (kapalabhati, bhastrika) should be approached cautiously in patients with cardiovascular comorbidities.
The depth of clinical evidence varies considerably across practices; methodological limitations (small samples, heterogeneous protocols, short follow-up) are widespread.

8. Closing Reflection

The convergence between contemplative traditions and modern neuroscience of Parkinson's is not a forced analogy. The systems the traditions developed practices to regulate — attention, breath, autonomic balance, emotional reactivity, identification with the body-mind — are the systems modern medicine has identified as central to the disease's progression and its non-motor burden. This convergence is itself a piece of data: the empirical adequacy of contemplative methods to act on the relevant biology is what allowed them to be transmitted across generations as therapies for the suffering of embodiment.

But the deeper offer of the non-dual traditions is not an alternative therapy. It is a different account of what the patient is. In the Advaitic framing, the body that has Parkinson's is real at one level and not the deepest level of what one is. This is neither a denial of the disease nor a magical claim about transcending it. It is a structural claim about identity: that consciousness is not exhausted by the brain it appears to depend on. Whether or not one accepts this metaphysically, the practice of holding such a view — sustained inquiry into the witness-quality of awareness, dis-identification from automatic narratives of "I am this failing body" — has measurable effects on the very neural systems whose failure constitutes the disease.

The patient may take this any way they wish. The traditions do not require belief; they invite investigation. And the science, for its part, no longer needs to apologize for taking that investigation seriously.

Selected References

Brown, R. P., & Gerbarg, P. L. (2005). Sudarshan Kriya yogic breathing in the treatment of stress, anxiety, and depression: Part I—Neurophysiologic model. Journal of Alternative and Complementary Medicine, 11(1), 189–201.

Bogosian, A., Hurt, C. S., Hindle, J. V., et al. (2022). Acceptance and Commitment Therapy for people with Parkinson's: a single-case experimental design. Behavioural and Cognitive Psychotherapy, 50(4), 392–407.

Cheung, C., Bhimani, R., Wyman, J. F., et al. (2018). Effects of yoga on oxidative stress, motor function, and non-motor symptoms in Parkinson's disease: a pilot randomized controlled trial. Pilot and Feasibility Studies, 4, 162.

Csikszentmihalyi, M. (1990). Flow: The Psychology of Optimal Experience. Harper & Row.

Dietrich, A. (2003). Functional neuroanatomy of altered states of consciousness: The transient hypofrontality hypothesis. Consciousness and Cognition, 12(2), 231–256.

Fox, K. C. R., Nijeboer, S., Dixon, M. L., et al. (2014). Is meditation associated with altered brain structure? A systematic review and meta-analysis of morphometric neuroimaging in meditation practitioners. Neuroscience & Biobehavioral Reviews, 43, 48–73.

Ghielen, I., van Wegen, E. E. H., Rutten, S., et al. (2017). Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: results from a pilot randomized controlled trial. Journal of Psychosomatic Research, 103, 1–8.

Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., & Lillis, J. (2006). Acceptance and Commitment Therapy: Model, processes and outcomes. Behaviour Research and Therapy, 44(1), 1–25.

Hemmerle, A. M., Herman, J. P., & Seroogy, K. B. (2012). Stress, depression and Parkinson's disease. Experimental Neurology, 233(1), 79–86.

Kjaer, T. W., Bertelsen, C., Piccini, P., Brooks, D., Alving, J., & Lou, H. C. (2002). Increased dopamine tone during meditation-induced change of consciousness. Cognitive Brain Research, 13(2), 255–259.

Kral, T. R. A., Schuyler, B. S., Mumford, J. A., et al. (2018). Impact of short- and long-term mindfulness meditation training on amygdala reactivity to emotional stimuli. NeuroImage, 181, 301–313.

Kwok, J. Y. Y., Kwan, J. C. Y., Auyeung, M., et al. (2019). Effects of mindfulness yoga vs stretching and resistance training exercises on anxiety and depression for people with Parkinson disease: a randomized clinical trial. JAMA Neurology, 76(7), 755–763.

Liddle, R. A. (2018). Parkinson's disease from the gut. Brain Research, 1693(Pt B), 201–206.

Liu, X., & Lu, H. (2023). Mindfulness or meditation therapy for Parkinson's disease: A systematic review and meta-analysis of randomized controlled trials. Acta Neurologica Scandinavica, 147(3), 247–258.

Mitarnun, W., Mitranun, W., Mitarnun, W., & Pangwong, W. (2022). Home-based walking meditation decreases disease severity in Parkinson's disease: A randomized controlled trial. Journal of Integrative and Complementary Medicine, 28(3), 215–223.

Pickut, B. A., Van Hecke, W., Kerckhofs, E., et al. (2013). Mindfulness based intervention in Parkinson's disease leads to structural brain changes on MRI: A randomized controlled longitudinal trial. Clinical Neurology and Neurosurgery, 115(12), 2419–2425.

Porges, S. W. (2011). The Polyvagal Theory: Neurophysiological Foundations of Emotions, Attachment, Communication, and Self-Regulation. W. W. Norton.

Tang, Y.-Y., Hölzel, B. K., & Posner, M. I. (2015). The neuroscience of mindfulness meditation. Nature Reviews Neuroscience, 16, 213–225.

van der Heide, A., Speckens, A. E. M., Meinders, M. J., et al. (2021). Stress and mindfulness in Parkinson's disease: clinical effects and potential underlying mechanisms. Movement Disorders, 36(1), 64–70.

Vivekananda, Swami. (1896/1955). Karma Yoga: The Yoga of Action. Advaita Ashrama, Calcutta.

Wang, X., et al. (2023). Whether mindfulness-guided therapy can be a new direction for the rehabilitation of patients with Parkinson's disease: a network meta-analysis. Frontiers in Psychology, 14, 1162574.

Wrosch, C., Scheier, M. F., Miller, G. E., Schulz, R., & Carver, C. S. (2003). Adaptive self-regulation of unattainable goals: Goal disengagement, goal reengagement, and subjective well-being. Personality and Social Psychology Bulletin, 29(12), 1494–1508.